Sumatriptan has been replaced as the most-prescribed serotonin1B/1D receptor agonist [triptan] in the top five European markets

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.448, 2004-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT 1B/1D Receptor Agonist for the Treatment of Migraine

By McEnroe Janet D.   Fleishaker Joseph C.  

Clinical Pharmacokinetics, Vol. 44, Iss. 3, 2005-01 ,pp. : 237-246

Adis International

Access to resources Recommend Favorite

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT 1B/1D receptor agonist

By Gupta P.   Butler P.   Shepperson N.B.   McHarg A.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite

Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraine

By Dahlof C.   Lines C.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 671-685

Informa Healthcare

Access to resources Recommend Favorite

Influence of vascular tone on vasoconstrictor responses to the 5-HT 1 -like receptor agonist sumatriptan in anaesthetised rabbits

By Choppin A.   O'Connor S.E.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 87-92

Elsevier

Access to resources Recommend Favorite

Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT 1D agonist sumatriptan

By Stern L.   Zohar J.   Cohen R.   Sasson Y.  

European Neuropsychopharmacology, Vol. 8, Iss. 4, 1998-12 ,pp. : 325-328

Elsevier

Access to resources Recommend Favorite